.jpg)
Singapore Exchange (SGX) today welcomed Singapore O&G Ltd (SOG) to Catalist under the stock code “41X”.
Founded in 2011, SOG is a regional provider of specialist healthcare for women, focusing on obstetrics, gynaecology, breast care services and gynae-oncology. With a group of specialist medical practitioners in women's healthcare and an established track record in the obstetrics and gynaecology field, SOG currently has eight clinics located in Singapore.
Dr Ng Koon Keng, CEO of the Group said: “We are elated at the overwhelming interest shown from the shareholders for our IPO. I would like to extend a warm welcome to our new shareholders as the Group embarks on its journey to expand its influence in the women’s healthcare industry in Singapore and the region. We truly are overwhelmed by the enthusiasm shown to us by the investing community here in Singapore and we look forward to enhancing our shareholders’ value to reinforce their confidence in Singapore O&G Ltd.”
Mohamed Nasser Ismail, Head of SME Development and Listings at SGX, said, “We are delighted to have Singapore O&G listed on Catalist, our fundraising platform for SMEs. This successful IPO once again demonstrates the strength of Singapore and SGX’s healthcare sector. With the growing demand for private and niche O&G services in Singapore and across the region, we look forward to continuing to support SOG in its expansion plans.”
The listing of SOG brings the total number of healthcare companies on SGX to 30 with a combined market capitalisation of over S$43 billion. Following SOG’s IPO, the Catalist board will have 159 companies valued at a total of about S$11 billion.
Shares of SOG opened at S$0.455, up 82%.
